IRIS - Res&Arch Institutional Research Information System - Research & Archive

CIPRIANI, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.300
EU - Europa 1.492
AS - Asia 1.298
SA - Sud America 223
AF - Africa 24
OC - Oceania 4
Totale 5.341
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.246
SG - Singapore 513
IE - Irlanda 318
IT - Italia 276
CN - Cina 231
HK - Hong Kong 229
BR - Brasile 199
VN - Vietnam 181
RU - Federazione Russa 174
UA - Ucraina 156
SE - Svezia 126
FI - Finlandia 92
DE - Germania 84
FR - Francia 57
GB - Regno Unito 55
TR - Turchia 42
EE - Estonia 36
CA - Canada 27
KR - Corea 27
MX - Messico 21
PL - Polonia 21
IN - India 20
CH - Svizzera 15
RO - Romania 14
AT - Austria 13
JP - Giappone 13
NL - Olanda 12
BE - Belgio 10
ES - Italia 10
AR - Argentina 9
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
BD - Bangladesh 7
LB - Libano 6
UZ - Uzbekistan 6
EC - Ecuador 5
KE - Kenya 5
PK - Pakistan 5
GR - Grecia 4
CL - Cile 3
CO - Colombia 3
HN - Honduras 3
IQ - Iraq 3
KG - Kirghizistan 3
LT - Lituania 3
AU - Australia 2
BN - Brunei Darussalam 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
MA - Marocco 2
NO - Norvegia 2
PH - Filippine 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
IL - Israele 1
KH - Cambogia 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
SA - Arabia Saudita 1
SR - Suriname 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.341
Salva come PNG Salva come JPEG
Città #
Chandler 396
Dublin 317
Singapore 294
Hong Kong 228
San Mateo 193
Dong Ket 134
Perugia 108
Boardman 101
Santa Clara 97
Ashburn 92
Ann Arbor 90
Altamura 88
Medford 78
Princeton 78
Beijing 73
Jacksonville 69
Lawrence 69
Moscow 65
Wilmington 64
Andover 63
Los Angeles 46
Columbus 33
Izmir 31
São Paulo 29
Des Moines 27
Saint Petersburg 27
Seoul 27
New York 26
Dearborn 21
Helsinki 21
Munich 21
Ho Chi Minh City 19
Houston 16
Timisoara 14
Warsaw 14
San Paolo di Civitate 12
Stockholm 12
Tokyo 12
Dallas 11
Norwalk 11
Redmond 11
Brussels 10
Chicago 10
Falls Church 10
London 10
Woodbridge 9
Den Haag 8
Mexico City 8
Nuremberg 8
The Dalles 8
Toronto 8
Turku 8
Vienna 8
Chennai 7
Frankfurt am Main 7
Manchester 7
Montreal 7
Olomouc 7
Redwood City 7
Rio de Janeiro 7
Rome 7
Ankara 6
Boston 6
Denver 6
Hanoi 6
Johannesburg 6
Nairobi 5
Phoenix 5
Brooklyn 4
Nanjing 4
Ribeirão Preto 4
San Francisco 4
Seattle 4
Atlanta 3
Bishkek 3
Carney 3
City of London 3
Giugliano In Campania 3
Guayaquil 3
New Delhi 3
Ninh Bình 3
Orem 3
Ottawa 3
Philadelphia 3
Piscataway 3
Poplar 3
Salvador 3
Shanghai 3
Vancouver 3
Americana 2
Antakya 2
Araruama 2
Arezzo 2
Bandar Seri Begawan 2
Barra Mansa 2
Bauru 2
Belo Horizonte 2
Betim 2
Bexley 2
Bucaramanga 2
Totale 3.429
Salva come PNG Salva come JPEG
Nome #
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 116
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 115
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 112
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 112
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 111
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 111
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 110
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 109
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 103
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 101
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 99
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 98
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 95
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 89
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 88
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 87
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 85
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 84
A Platelet's Guide to Synovitis 83
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 80
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 80
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 79
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 79
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 78
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 78
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 77
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 77
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 75
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 73
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 73
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 72
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 72
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 72
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 71
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 70
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 69
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 68
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 68
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 67
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 65
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 64
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 64
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. 64
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 63
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 63
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 63
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 61
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 61
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 59
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 59
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 58
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 58
Nanotraps with biomimetic surface as decoys for chemokines 58
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 57
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 55
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 55
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 54
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 53
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 53
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 52
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 52
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 51
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 51
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 51
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 50
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 49
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 46
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 45
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 45
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 45
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 44
Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis 44
Dietary habits and semen parameters: a systematic narrative review 44
Preterm Birth, Low Gestational Age, Low Birth Weight, Parity, and Other Determinants of Breech Presentation: Results from a Large Retrospective Population-Based Study 44
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 41
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 39
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. 39
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 37
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 35
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 35
Totale 5.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021462 0 0 0 0 179 21 25 8 32 16 32 149
2021/2022676 7 132 2 34 31 7 14 223 8 32 85 101
2022/20231.223 81 243 7 124 115 116 0 62 431 1 32 11
2023/2024394 31 52 25 3 2 2 97 13 10 20 84 55
2024/20251.161 16 88 47 42 166 66 28 69 231 71 196 141
2025/2026901 152 145 145 270 189 0 0 0 0 0 0 0
Totale 5.512